Sodium Nitroprusside
Active substance: sodium nitroprusside
INJECTION · SODIUM NITROPRUSSIDE 50 mg/2mL
United StatesActive
Marketing holder: BE Pharmaceuticals Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- SODIUM NITROPRUSSIDE · 50 mg/2mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-276a-7f47-8b2d-2a5d0335bfd0,01a1208c-490b-79db-9529-310cea2dba8b,01a1208c-9f43-7b6c-83f0-17559629bec9,01a1208c-9f4c-73e3-a385-039254716d3e,01a1208c-fc90-7a86-bc55-f04adfe1c942;count=22 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 71839-120
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
Sources
- product · openFDA NDC · 71839-120 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 71839-120 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 71839-120 · Verified 2026-10-09 · open in source